Kallyope is a pioneering biotechnology company based in New York City, focused on harnessing the potential of the gut-brain axis. The company leverages cutting-edge technologies in genomics, neuroscience, and human biology to develop innovative therapies for chronic diseases, including metabolic disorders and gastrointestinal health issues. Their research aims to unlock new pathways for drug development by understanding how the gut communicates...read more
kallyope.com
Jay Galeota
CEO & President
Patrick Flanigan
Chief Financial Officer